NYSE:HCA (USA) Also trade in: Germany Mexico UK

HCA Healthcare Inc

$ 139.48 -1.75 (-1.24%)
Volume: 1,091,141 Avg Vol (1m): 1,665,094
Market Cap $: 47.75 Bil Enterprise Value $: 84.13 Bil
P/E (TTM): 13.35 P/B: 0.00
Earnings Power Value -27.36
Net Current Asset Value -104.55
Tangible Book -35.72
Projected FCF 88.53
Median P/S Value 100.17
Graham Number 0
Peter Lynch Value 141.57
DCF (FCF Based) 173.75
DCF (Earnings Based) 111.73
1Y (-%)

Financial Strength : 3.8/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.02
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.02, Max: 0.14
Current: 0.02
0
0.14
Equity-to-Asset -0.10
Equity-to-Asset range over the past 10 years
Min: -0.5, Med: 0.21, Max: 0.42
Current: -0.1
-0.5
0.42
Debt-to-Equity -8.00
Debt-to-Equity range over the past 10 years
Min: -8, Med: 0.86, Max: 4.71
Current: -8
-8
4.71
Debt-to-EBITDA 3.71
Debt-to-EBITDA range over the past 10 years
Min: 3.5, Med: 4.11, Max: 4.91
Current: 3.71
3.5
4.91
Interest Coverage 3.92
Interest Coverage range over the past 10 years
Min: 1.91, Med: 2.94, Max: 3.92
Current: 3.92
1.91
3.92
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.16
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC 19.52%
WACC 7.29%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 14.65
Operating Margin range over the past 10 years
Min: 12.65, Med: 14.6, Max: 15.07
Current: 14.65
12.65
15.07
Net Margin % 7.71
Net Margin range over the past 10 years
Min: 3.51, Med: 5.08, Max: 8.3
Current: 7.71
3.51
8.3
ROA % 9.41
ROA range over the past 10 years
Min: 4.35, Med: 6.29, Max: 9.99
Current: 9.41
4.35
9.99
ROC (Joel Greenblatt) % 30.92
ROC (Joel Greenblatt) range over the past 10 years
Min: 28.41, Med: 30.64, Max: 37.66
Current: 30.92
28.41
37.66
3-Year Total Revenue Growth Rate 5.60
3-Year Revenue Growth Rate range over the past 10 years
Min: -7.8, Med: 8.55, Max: 24.3
Current: 12.2
-7.8
24.3
3-Year Total EBITDA Growth Rate 7.60
3-Year EBITDA Growth Rate range over the past 10 years
Min: -40.4, Med: 9.6, Max: 76.1
Current: 14.3
-40.4
76.1
3-Year EPS w/o NRI Growth Rate 28.80
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 12.7, Max: 88.4
Current: 28.8
0
88.4

» HCA's 30-Y Financials

Financials (Next Earnings Date: 2019-07-30)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:HCA

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Health Care Providers    NAICS : 622110    SIC : 8062
Compare XTER:FRE XTER:FME SZSE:300015 BKK:BDMS-F XKLS:5225 NYSE:UHS ASX:RHC NYSE:DVA ASX:SHL BSP:HAPV3 LSE:NMC NYSE:EHC NYSE:CHE BKK:BH-Q NAS:AMED NAS:LHCG NAS:ACHC LSE:MDC NSE:APOLLOHOSP NYSE:AMN
Traded in other countries 2BH.Germany 0J1R.UK
Address One Park Plaza, Nashville, TN, USA, 37203
Accounting for about 5% of total U.S. hospital admissions, HCA is the largest private hospital owner and operator in the United States. It operates 170 hospitals and 118 outpatient centers, offering a broad range of health services. HCA has operations in 20 states and in England, but a majority of its operations are in the Southern United States, particularly in Florida and Texas. Outpatient services make up about 40% of HCA's patient revenue.

Ratios

Current vs industry vs history
PE Ratio (TTM) 13.35
PE Ratio range over the past 10 years
Min: 4.08, Med: 13.27, Max: 19.72
Current: 13.35
4.08
19.72
Forward PE Ratio 13.79
N/A
PE Ratio without NRI 13.35
PE without NRI range over the past 10 years
Min: 4.08, Med: 13.27, Max: 19.72
Current: 13.35
4.08
19.72
Price-to-Owner-Earnings 16.74
Price-to-Owner-Earnings range over the past 10 years
Min: 2.31, Med: 13.87, Max: 43.21
Current: 16.74
2.31
43.21
PS Ratio 1.03
PS Ratio range over the past 10 years
Min: 0.32, Med: 0.74, Max: 1.12
Current: 1.03
0.32
1.12
Price-to-Free-Cash-Flow 17.63
Price-to-Free-Cash-Flow range over the past 10 years
Min: 4.08, Med: 12.08, Max: 20.84
Current: 17.63
4.08
20.84
Price-to-Operating-Cash-Flow 7.63
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.57, Med: 5.96, Max: 8.64
Current: 7.63
2.57
8.64
EV-to-EBIT 11.94
EV-to-EBIT range over the past 10 years
Min: 6.3, Med: 10.7, Max: 12.6
Current: 11.94
6.3
12.6
EV-to-EBITDA 8.97
EV-to-EBITDA range over the past 10 years
Min: 5, Med: 7.9, Max: 9.4
Current: 8.97
5
9.4
EV-to-Revenue 1.76
EV-to-Revenue range over the past 10 years
Min: 1.2, Med: 1.5, Max: 1.9
Current: 1.76
1.2
1.9
PEG Ratio 1.02
PEG Ratio range over the past 10 years
Min: 0.51, Med: 1.75, Max: 4.62
Current: 1.02
0.51
4.62
Shiller PE Ratio 23.37
Shiller PE Ratio range over the past 10 years
Min: 6.16, Med: 16.5, Max: 25.8
Current: 23.37
6.16
25.8
Current Ratio 1.05
Current Ratio range over the past 10 years
Min: 0.81, Med: 1.51, Max: 2.25
Current: 1.05
0.81
2.25
Quick Ratio 0.89
Quick Ratio range over the past 10 years
Min: 0.71, Med: 1.34, Max: 2.12
Current: 0.89
0.71
2.12
Days Inventory 20.83
Days Inventory range over the past 10 years
Min: 17.77, Med: 19.82, Max: 57.7
Current: 20.83
17.77
57.7
Days Sales Outstanding 56.69
Days Sales Outstanding range over the past 10 years
Min: 44.84, Med: 53.63, Max: 56.69
Current: 56.69
44.84
56.69
Days Payable 33.17
Days Payable range over the past 10 years
Min: 30.44, Med: 32.22, Max: 109.47
Current: 33.17
30.44
109.47

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 1.08
Trailing Dividend Yield range over the past 10 years
Min: 0.34, Med: 0.79, Max: 1.26
Current: 1.08
0.34
1.26
Dividend Payout Ratio 0.14
Dividend Payout Ratio range over the past 10 years
Min: 0.13, Med: 0.13, Max: 0.14
Current: 0.14
0.13
0.14
Forward Dividend Yield % 1.15
N/A
Yield-on-Cost (5-Year) % 1.07
Yield-on-Cost (5y) range over the past 10 years
Min: 0.34, Med: 0.79, Max: 1.26
Current: 1.07
0.34
1.26
3-Year Share Buyback Rate 4.80
3-Year Share Buyback Rate range over the past 10 years
Min: -202.3, Med: 1.3, Max: 12
Current: 4.8
-202.3
12

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.58
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.26, Med: 2.14, Max: 17.96
Current: 1.58
1.26
17.96
Price-to-DCF (Earnings Based) 1.25
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.81, Med: 1.31, Max: 1.73
Current: 1.25
0.81
1.73
Price-to-Median-PS-Value 1.39
Price-to-Median-PS-Value range over the past 10 years
Min: 0.48, Med: 0.99, Max: 1.46
Current: 1.39
0.48
1.46
Price-to-Peter-Lynch-Fair-Value 0.99
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.58, Med: 1.65, Max: 3.69
Current: 0.99
0.58
3.69
Earnings Yield (Joel Greenblatt) % 8.37
Earnings Yield (Greenblatt) range over the past 10 years
Min: 8, Med: 9.3, Max: 16
Current: 8.37
8
16
Forward Rate of Return (Yacktman) % 18.13
Forward Rate of Return range over the past 10 years
Min: 9.8, Med: 15.2, Max: 19.8
Current: 18.13
9.8
19.8

More Statistics

Revenue (TTM) (Mil) $ 47,771
EPS (TTM) $ 10.44
Beta 1.25
Volatility % 33.75
52-Week Range $ 105.64 - 147.42
Shares Outstanding (Mil) 342.31

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N